Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01161056 · ClinicalTrials.gov registry record

Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
5,000
Enrollment target

NCT01161056: Completed study, sponsored by Northwell Health.

NCT01161056 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 5,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01161056 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
5,000 participants
Enrollment target

Study Summary

The purpose of this study is to enrol generally healthy adults, who are asked to provide a blood sample, to study how the immune system works.

Primary Outcome

This is a registry to enroll healthy individuals who are interested in being contacted about research studies they can participate in as a healthy control

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2009-05
Est. Completion 2015-04
Northwell Health

370 total trials

What the finished NCT01161056 record still lists

NCT01161056 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01161056 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01161056 about?

NCT01161056 is a clinical study titled "Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways". The purpose of this study is to enrol generally healthy adults, who are asked to provide a blood sample, to study how the immune system works.

What is the current status of trial NCT01161056?

This trial is currently completed. The enrollment target is 5,000 participants. The study started on 2009-05. Estimated completion is 2015-04.

Who is sponsoring clinical trial NCT01161056?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01161056, the US trial registry maintained by the National Library of Medicine. NCT01161056 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.